Hypertension. a Companion to Braunwald's Heart Disease

DESCRIPTION

Clinical hypertension is one of the most serious long-term problems associated with heart disease. This companion to BRAUNWALD'S HEART DISEASE focuses in depth on this key area of cardiovascular medicine. Complete with practical clinical tools for management, it helps you manage the chronic problems of your hypertensive patients. It covers everything from epidemiology and pathophysiology through diagnosis, risk stratification, treatment, outcome studies, concomitant diseases, special populations and special situations, and future treatments.

KEY FEATURES

• Confidently meet the needs of special populations with chronic hypertensive disease, as well as hypertension and concomitant disease.
• Learn new methods of aggressive patient management and disease prevention to help ensure minimal risk of further cardiovascular problems.
• Benefit from the authors' Clinical Pearls to reduce complications of hypertension.

NEW TO THIS EDITION

• Use new combination drug therapies and other forms of treatment to their greatest advantage in the management of chronic complications of hypertension.
• Successfully employ behavior management as a vital part of the treatment plan for hypertensives and pre-hypertensives.
• Access the complete contents online and download images at www.expertconsult.com.

TABLE OF CONTENTS

SECTION I: EPIDEMIOLOGY AND PATHOPHYSIOLOGY

• 1. Epidemiology of Hypertension
• 2. Pathogenesis of Hypertension

SECTION II: DIAGNOSIS

• 3. Defining Hypertension
• 4. Office Blood Pressure Measurement
• 5. Home Monitoring of Blood Pressure
• 6. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
• 7. White Coat and Masked Hypertension
• 8. Secondary Hypertension: Renovascular Hypertension
• 9. Secondary Hypertension: Renin-Independent Mineralocorticoid Excess States
• 10. Secondary Hypertension: Pheochromocytoma
• 11. Secondary Hypertension: Sleep Apnea
• 12. Rare and Unusual Forms of Hypertension

SECTION III: RISK STRATIFICATION

• 13. The Natural History of Untreated Hypertension
• 14. The Special Problem of Isolated Systolic Hypertension
• 15. Assessment of Hypertensive Target Organ Damage
• 16. Prediction of Global Cardiovascular Risk in Hypertension

SECTION IV: TREATMENT

• 17. Diet and Blood Pressure
• 18. Diuretic Therapy in Cardiovascular Disease
• 19. ?-Blockers in Hypertension
• 20. Angiotensin-Converting Enzyme Inhibitors
• 21. Angiotensin Receptor Blockers
• 22. Calcium Channel Blockers in Hypertension
• 23. a-Blockers
• 24. New Drugs for Hypertension
• 25. Devices for Hypertension

SECTION V: OUTCOME STUDIES

• 26. Design of Outcomes Studies
• 27. Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists' Collaboration

SECTION VI: HYPERTENSION AND CONCOMITANT DISEASES

• 28. Ischemic Heart Disease in Hypertension
• 29. Heart Failure in Hypertension
• 30. Kidney Disease in Hypertension
• 31. Transplant Hypertension
• 32. Obesity in Hypertension
• 33. Peripheral Artery Disease in Hypertension
• 34. Cerebrovascular Disease in Hypertension
• 35. Hypertension and Diabetes Mellitus: An Update
• 36. Dyslipidemia in Hypertension

SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS

• 37. Hypertension in Pregnancy
• 38. Hypertension in Children and Adolescents
• 39. Hypertension in Older Patients
• 40. Hypertension in African Americans
• 41. Hypertension in Hispanics
• 42. Hypertension in East Asians and Native Hawaiians
• 43. Hypertension in South Asians
• 44. Resistant Hypertension
• 45. Hypertension and the Perioperative Period
• 46. Hypertensive Emergencies and Urgencies

SECTION VIII: HYPERTENSION TREATMENT IN THE FUTURE

• 47. Team-Based Care for the Management of Hypertension
• 48. Outcomes Research in Hypertension
• 49. Pharmacogenetics of Antihypertensive Treatment
• 50. Antihypertensive Drug Development: A Regulatory Perspective

SECTION IX: GUIDELINES

• 51. U.S. and Canadian Hypertension Guidelines
• 52. European and British Guidelines on Hypertension

AUTHOR INFORMATION

By Henry R. Black, MD, Associate Vice President for Research, Charles J. and Margaret Roberts Professor; Chairman, Department of Preventive Medicine, Rush University Medical Center, Chicago, IL, USA and William Elliott, MD, PhD, Professor, Department of Preventive Medicine, Rush University Medical Center. Chicago, IL, USA